ProjectAnalysis of Tumor-associated antigens (TAAs) in childhood melanoma4
Basic data
Title:
Analysis of Tumor-associated antigens (TAAs) in childhood melanoma4
Duration:
14/06/2021 to 14/06/2022
Abstract / short description:
RNA based cancer vaccines can induce an immune response directed against tumor antigens in melanoma patients (1). The investigational drug FixVac (BNT111) targets four non-mutated, tumor-associated antigens that are expressed in adult melanoma. However, there is no data available regarding expression of these antigens in childhood melanoma. The goal of this study is to examine the expression of TAAs in childhood melanoma in the context of developing FixVac (BNT111) for the treatment of childhood melanomas.
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Mainz, Rheinland-Pfalz, Germany